Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085150
Status:
COMPLETED
Last Update Posted:
2015-04-30
First Post:
2004-06-10
Brief Title:
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| acute undifferentiated leukemia | View |
| recurrent adult T-cell leukemialymphoma | View |
| recurrent childhood acute lymphoblastic leukemia | View |
| childhood Burkitt lymphoma | View |
| recurrent childhood acute myeloid leukemia | View |
| recurrent childhood large cell lymphoma | View |
| recurrent childhood lymphoblastic lymphoma | View |
| recurrent mycosis fungoidesSezary syndrome | View |
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| recurrentrefractory childhood Hodgkin lymphoma | View |
| relapsing chronic myelogenous leukemia | View |